Coming conference on antiangiogenesis (Oct 16-17)
For those who may want to attend the 2 day conference in Boston:
http://www.ibclifesciences.com/antiangio October 16-17, 2006 - Sheraton Boston Hotel - Boston, MA Part of the agenda is including: Explore new targets for antiangiogenic therapy and receive clinical updates of agents now in development Amgen, GlaxoSmithKline, Pfizer and Bayer share their latest clinical results and updates Genentech describes their research on neuropilin-1, a new potential angiogenesis target ARIAD Pharmaceuticals offers an in-depth look at mTOR inhibition for dual targeting of tumor prolifieration and angiogenesis Dana Farber Cancer Center provides new data showing metronomic chemotherapy as anti-angiogenic treatment |
heblaj--did you look at the prices to attend?
$499 to $1399 !!!
|
Lani,
No, I did not notice the price tag to attend. I guess only snicking in by the back door will be the only low entry price! |
All times are GMT -7. The time now is 01:43 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021